APIDRA J Code: J1815
Injection, insulin, per 5 units
Drug & Product Overview
About APIDRA
Apidra is a medication aligned to the HCPCS J Code: J1815 for billing, pricing, and reimbursement purposes in the United States. This Insulin medication is administered via the intravenous or subcutaneous routes and manufactured by multiple companies.
Manufacturers, reach out to us to add more information.
NDC Code Information
21 NDC packages are crosswalked to J1815. Package detail is available to logged-in subscribers.
| NDC Code | Drug | Manufacturer | Billing Units / Pkg | Package Size |
|---|---|---|---|---|
| •••••-••••-•• Log in to view | APIDRA | •••••••••••• Log in to view | •••• Log in to view | ••• •• / • •• Log in to view |
| •••••-••••-•• Log in to view | APIDRA | •••••••••••• Log in to view | •••• Log in to view | ••• •• / • •• Log in to view |
| •••••-••••-•• Log in to view | APIDRA | •••••••••••• Log in to view | •••• Log in to view | ••• •• / • •• Log in to view |
| •••••-••••-•• Log in to view | APIDRA | •••••••••••• Log in to view | •••• Log in to view | ••• •• / • •• Log in to view |
APIDRA Pricing & Reimbursement
National median reimbursement across major commercial payers.
Create an account on PayerPrice for more information →Biosimilar Information
APIDRA Approval Date: October 28, 1982
| Product Name | HCPCS Code | Active Ingredient | BLA Type |
|---|---|---|---|
| FIASP | J1815 | Insulin Aspart | 351(a) Originator Product |
| NOVOLOG | J1817 | Insulin Aspart | 351(a) Originator Product |
| KIRSTY | N/A | Insulin Aspart | 351(K) Interchangeable |
| MERILOG | N/A | Insulin Aspart | 351(K) Biosimilar |
APIDRA CPT Administration Codes
The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.
| CPT Code | Description |
|---|---|
| 96372 | Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intramuscular |
CMS does not include Apidra (J1815) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J1815. Wastage billing guide →
APIDRA Medically Unlikely Edits (MUE)
The most billing units of J1815 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 5 units. The limit is different in the office and the hospital. Use the one for your setting.
MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →
APIDRA Clinical Information
Indications and drug classification.
This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.
Login for BuyandBill.com Analytics
Unlock deeper insights with BuyandBill’s Comparative Report!
- Compare ASP, WAC, and AWP across drugs.
- Visualize Drug Price Movement Over Time
- Tailor reports to drug class, manufacturer, or HCPCS Code.
- Compare Biosimilar and 505(b)(2) products.
Frequently Asked Questions
Is there an available Apidra billing and coding guide?
Are there any available Apidra patient assistance programs?
Where can I find Apidra prescribing information?
Where can I find Apidra side effect information?
Does billing APIDRA require JZ/JW wastage modifiers?
About BuyandBill.com:
The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.
Related Drug Codes
Explore billing, coding, and pricing for drugs related to APIDRA.